https://www.hcplive.com/watch 0.50 https://www.hcplive.com/peer-exchange/changing-treatment-approaches-in-the-management-of-plaque-psoriasis 2021-12-08 0.50 https://www.hcplive.com/peer-exchange/practice-perspectives-on-optimal-patient-care-in-the-management-of-psoriatic-arthritis 2022-02-08 0.50 https://www.hcplive.com/peer-exchange/biologics-treatment-selection-in-patients-with-moderate-to-severe-asthma 2023-06-05 0.50 https://www.hcplive.com/peer-exchange/optimizing-outpatient-care-clinical-strategies-for-managing-hepatic-encephalopathy 2024-06-07 0.50 https://www.hcplive.com/peer-exchange/advances-in-treatment-of-primary-biliary-cholangitis-pbc 2023-06-05 0.50 https://www.hcplive.com/peer-exchange/iron-deficiency-anemia-across-specialties-optimizing-patient-outcomes-through-collaborative-care 2024-08-05 0.50 https://www.hcplive.com/peer-exchange/delaying-the-onset-of-type-1-diabetes-through-early-intervention 2023-07-17 0.50 https://www.hcplive.com/peer-exchange/evaluation-and-management-of-real-world-cases-of-psoriatic-arthritis 2021-11-18 0.50 https://www.hcplive.com/peer-exchange/bridging-the-gaps-in-iga-nephropathy-recognizing-disease-earlier-and-advancing-targeted-care 2026-07-23 0.50 https://www.hcplive.com/peer-exchange/managing-growth-hormone-deficiency-across-the-continuum-of-care 2026-04-28 0.50 https://www.hcplive.com/peer-exchange/advances-in-treatment-of-obstructive-hypertrophic-cardiomyopathy 2022-04-28 0.50 https://www.hcplive.com/peer-exchange/tailoring-treatment-approaches-in-psoriasis-management 2025-03-17 0.50 https://www.hcplive.com/peer-exchange/personalizing-treatment-selection-in-atopic-dermatitis 2023-01-25 0.50 https://www.hcplive.com/peer-exchange/defining-drug-remission-in-psoriasis-long-term-data-and-insights 2026-04-10 0.50 https://www.hcplive.com/peer-exchange/sleep-disorders-and-health-conditions-focus-on-insomnia 2023-03-21 0.50 https://www.hcplive.com/peer-exchange/advancing-wilson-disease-care-evolving-approaches-for-copper-control 2026-04-08 0.50 https://www.hcplive.com/peer-exchange/examining-the-true-prevalence-of-hypercortisolism-and-its-impact-on-managing-resistant-diabetes 2024-08-07 0.50 https://www.hcplive.com/peer-exchange/evolving-the-hs-treatment-paradigm-long-term-outcomes-with-il-17-inhibition 2025-10-02 0.50 https://www.hcplive.com/peer-exchange/review-of-current-and-novel-treatment-pathways-to-manage-plaque-psoriasis 2021-12-20 0.50 https://www.hcplive.com/peer-exchange/evolving-treatment-paradigms-in-hypercortisolism-integrating-emerging-evidence-into-practice 2025-06-23 0.50 https://www.hcplive.com/peer-exchange/an-expert-nurse-practitioner-and-physician-assistant-exchange-on-the-management-of-pediatric 2022-08-29 0.50 https://www.hcplive.com/peer-exchange/targeting-structural-damage-in-psoriatic-arthritis-the-impact-of-early-recognition-and-timely 2025-08-08 0.50 https://www.hcplive.com/peer-exchange/advances-in-the-management-and-treatment-of-dry-eye-disease 2023-03-31 0.50 https://www.hcplive.com/peer-exchange/emerging-treatment-options-for-geographic-atrophy 2022-11-07 0.50 https://www.hcplive.com/peer-exchange/current-and-emerging-treatment-options-for-age-related-macular-degeneration 2021-11-08 0.50 https://www.hcplive.com/peer-exchange/advances-in-microbiome-based-therapies-for-recurrent-c-difficile-infection 2023-05-04 0.50 https://www.hcplive.com/peer-exchange/optimizing-outcomes-when-using-biologics-for-treatment-of-psoriasis 2024-03-26 0.50 https://www.hcplive.com/peer-exchange/advancing-igan-care-exploring-the-next-wave-of-treatments 2025-05-27 0.50 https://www.hcplive.com/peer-exchange/advances-in-targeted-therapy-selection-in-rheumatoid-arthritis 2022-12-07 0.50 https://www.hcplive.com/peer-exchange/dual-orexin-receptor-antagonists-for-treatment-of-insomnia 2023-12-21 0.50 https://www.hcplive.com/peer-exchange/curing-your-patients-from-hepatitis-c-addressing-complex-needs-with-simplified-treatment 2023-11-14 0.50 https://www.hcplive.com/peer-exchange/addressing-patient-needs-in-seborrheic-dermatitis-with-novel-therapies 2024-05-13 0.50 https://www.hcplive.com/peer-exchange/advances-in-the-management-of-adhd-in-adult-population 2022-03-21 0.50 https://www.hcplive.com/peer-exchange/clinical-strategies-for-managing-resistant-hypertension-emerging-tools-and-therapeutic-insights 2025-06-27 0.50 https://www.hcplive.com/peer-exchange/examining-the-long-term-clinical-evidence-of-therapies-for-inflammatory-bowel-disease-in-bio 2024-05-13 0.50 https://www.hcplive.com/peer-exchange/frontline-management-of-atopic-dermatitis-in-adults 2025-05-27 0.50 https://www.hcplive.com/peer-exchange/evidence-based-strategies-for-copd-diagnosis-management-and-prevention 2025-05-27 0.50 https://www.hcplive.com/peer-exchange/the-relationship-between-the-gut-microbiome-and-management-of-c-difficile 2021-11-19 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-advances-in-the-management-of-major-depressive-disorder 2022-12-14 0.50 https://www.hcplive.com/peer-exchange/advancing-ckd-and-cardiovascular-risk-management-through-diagnostic-testing 2026-02-16 0.50 https://www.hcplive.com/peer-exchange/treatment-of-familial-chylomicronemia-syndrome-a-multidisciplinary-approach 2024-11-27 0.50 https://www.hcplive.com/peer-exchange/novel-expert-perspectives-in-treating-moderate-to-severe-ulcerative-colitis 2022-06-07 0.50 https://www.hcplive.com/peer-exchange/recent-approvals-in-vaccination-against-sars-cov-2-and-the-omicron-subvariants 2022-10-24 0.50 https://www.hcplive.com/peer-exchange/jak-inhibitors-for-the-management-of-atopic-dermatitis-ad 2022-04-26 0.50 https://www.hcplive.com/peer-exchange/advancing-hypertension-management-unmet-needs-endothelial-dysfunction-and-ckd-therapies 2024-12-02 0.50 https://www.hcplive.com/peer-exchange/advances-and-unmet-needs-in-the-management-of-plaque-psoriasis-expert-advanced-practice-provider-perspectives 2022-12-16 0.50 https://www.hcplive.com/peer-exchange/optimizing-anti-vegf-treatment-outcomes-in-neovascular-amd-and-dme 2023-03-16 0.50 https://www.hcplive.com/peer-exchange/understanding-hypercortisolism-and-its-impact-on-cardiovascular-diseases 2026-04-08 0.50 https://www.hcplive.com/peer-exchange/optimizing-psoriasis-care-navigating-the-role-of-il-23-inhibitors-with-comparative-evidence 2026-03-13 0.50 https://www.hcplive.com/peer-exchange/the-evolving-treatment-landscape-of-atopic-dermatitis-and-other-dermatological-conditions 2023-04-27 0.50 https://www.hcplive.com/peer-exchange/closing-the-gaps-in-exocrine-pancreatic-insufficiency-care-improving-diagnosis-dosing-and-care 2026-04-08 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-novel-treatment-options-for-ascvd-hypercholesterolemia 2022-04-25 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-the-utility-of-real-world-data-in-the-management-of-plaque-psoriasis 2022-12-20 0.50 https://www.hcplive.com/peer-exchange/understanding-red-blood-cell-health-and-the-management-of-sickle-cell-disease 2022-09-07 0.50 https://www.hcplive.com/peer-exchange/emerging-treatment-options-for-the-management-of-sickle-cell-disease 2022-02-15 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-managing-polyvascular-disease-and-coronary-artery-disease 2022-04-28 0.50 https://www.hcplive.com/peer-exchange/novel-topical-treatments-in-the-management-of-plaque-psoriasis 2023-06-16 0.50 https://www.hcplive.com/peer-exchange/improving-pediatric-atopic-dermatitis-care-across-all-severities-with-topical-therapeutics 2025-10-13 0.50 https://www.hcplive.com/peer-exchange/turning-the-tide-early-pcsk9-intervention-post-acs 2025-04-02 0.50 https://www.hcplive.com/peer-exchange/il-13-targeting-biologics-for-the-treatment-of-atopic-dermatitis 2024-12-24 0.50 https://www.hcplive.com/peer-exchange/closing-the-ldl-c-gap-optimizing-lipid-lowering-therapy-in-ascvd 2026-04-23 0.50 https://www.hcplive.com/peer-exchange/advances-in-the-management-of-adhd-in-the-adult-population 2022-10-26 0.50 https://www.hcplive.com/peer-exchange/practical-strategies-for-identifying-and-screening-for-hypercortisolism 2025-04-17 0.50 https://www.hcplive.com/peer-exchange/advances-in-the-management-of-prurigo-nodularis 2022-12-02 0.50 https://www.hcplive.com/peer-exchange/elevating-copd-management-enhancing-treatment-and-improving-patient-outcomes 2025-06-26 0.50 https://www.hcplive.com/peer-exchange/advances-in-primary-biliary-cholangitis-expert-insights-on-emerging-data-and-key-treatment 2026-01-22 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-in-the-management-of-pediatric-atopic-dermatitis 2022-07-20 0.50 https://www.hcplive.com/peer-exchange/practical-management-of-atopic-dermatitis-nurse-practitioner-and-physician-assistant-perspective 2021-07-14 0.50 https://www.hcplive.com/peer-exchange/navigating-giant-cell-arteritis-diagnosis-management-and-the-road-ahead 2025-11-24 0.50 https://www.hcplive.com/peer-exchange/unmet-needs-in-treating-insomnia 2021-12-20 0.50 https://www.hcplive.com/peer-exchange/understanding-cortisol-control-in-hypercortisolism-with-expanded-screening-across-type-2 2026-06-23 0.50 https://www.hcplive.com/peer-exchange/expanding-treatment-options-for-primary-biliary-cholangitis-with-novel-therapies 2024-11-13 0.50 https://www.hcplive.com/peer-exchange/emerging-treatment-options-for-recurrent-c-difficile-infection 2022-07-20 0.50 https://www.hcplive.com/peer-exchange/advancing-treatment-for-c3g-targeting-the-complement-system-for-personalized-kidney-care 2025-04-11 0.50 https://www.hcplive.com/peer-exchange/redefining-psoriasis-care-expert-perspectives-of-emerging-data-on-novel-treatment-modalities 2025-11-13 0.50 https://www.hcplive.com/peer-exchange/emerging-evidence-to-guide-patient-centric-treatment-selection-for-heart-failure 2023-06-13 0.50 https://www.hcplive.com/peer-exchange/elevating-psoriasis-care-the-role-of-il-17-inhibition-in-advancing-on-treatment-remission 2026-07-22 0.50 https://www.hcplive.com/peer-exchange/optimizing-treatment-of-psoriasis-in-patients-with-skin-of-color 2024-03-05 0.50 https://www.hcplive.com/peer-exchange/targeting-objective-treatment-goals-in-crohn-s-disease 2023-12-19 0.50 https://www.hcplive.com/peer-exchange/breaking-down-biologics-in-atopic-dermatitis-choosing-the-right-path-for-patients 2025-03-19 0.50 https://www.hcplive.com/peer-exchange/advances-in-the-management-of-atopic-dermatitis 2021-09-13 0.50 https://www.hcplive.com/peer-exchange/evolving-frontiers-in-iga-nephropathy-emerging-strategies-in-treatment-and-care 2025-11-24 0.50 https://www.hcplive.com/peer-exchange/multidisciplinary-perspectives-on-the-effective-therapeutic-approaches-and-quality-of-life-consi 2021-07-15 0.50 https://www.hcplive.com/peer-exchange/enhancing-ckd-care-in-type-2-diabetes-bridging-gaps-in-diagnosis-treatment-and-patient-outcomes 2024-11-07 0.50 https://www.hcplive.com/peer-exchange/optimizing-outcomes-in-hypoparathyroidism-a-new-era-in-treatment-approaches 2026-01-12 0.50 https://www.hcplive.com/peer-exchange/roles-for-vegf-inhibitors-in-the-management-of-retinal-diseases 2022-02-09 0.50 https://www.hcplive.com/peer-exchange/identifying-hypercortisolism-in-patients-with-resistant-diabetes 2024-05-09 0.50 https://www.hcplive.com/peer-exchange/advances-and-unmet-needs-in-the-management-of-plaque-psoriasis-expert-advanced-practice-provider 2022-10-28 0.50 https://www.hcplive.com/peer-exchange/emerging-pathways-in-copd-targeting-type-2-inflammation-for-a-tailored-treatment-approach 2024-05-20 0.50 https://www.hcplive.com/peer-exchange/remission-realized-achieving-disease-control-in-your-patients-with-rheumatoid-arthritis 2024-10-31 0.50 https://www.hcplive.com/peer-exchange/understanding-hypertrophic-cardiomyopathy-from-disease-mechanisms-to-clinical-management 2026-04-07 0.50 https://www.hcplive.com/peer-exchange/optimizing-anticoagulation-in-vascular-disease-patients-reimagining-the-standard-of-care 2022-03-10 0.50 https://www.hcplive.com/peer-exchange/shifting-the-treatment-paradigm-of-severe-asthma-with-novel-biologics 2021-12-20 0.50 https://www.hcplive.com/peer-exchange/restoring-skin-pigmentation-in-vitiligo-with-advanced-treatments 2023-04-10 0.50 https://www.hcplive.com/peer-exchange/navigating-therapeutic-pathways-and-transforming-care-in-attr-cm 2025-11-17 0.50 https://www.hcplive.com/peer-exchange/utilization-of-corticosteroid-delivery-systems-for-treatment-of-nasal-polyposis 2022-10-21 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-in-the-management-of-opioid-induced-constipation 2022-06-28 0.50 https://www.hcplive.com/peer-exchange/improving-recognition-of-hypercortisolism-in-patients-with-hypertension-and-cardiovascular 2026-06-29 0.50 https://www.hcplive.com/peer-exchange/management-of-type-2-inflammation-in-atopic-dermatitis 2022-04-15 0.50 https://www.hcplive.com/peer-exchange/clinical-management-of-diabetic-macular-edema 2022-02-09 0.50 https://www.hcplive.com/peer-exchange/jak-inhibitors-in-the-evolving-treatment-landscape-of-atopic-dermatitis 2023-10-31 0.50 https://www.hcplive.com/peer-exchange/improving-quality-of-life-in-atopic-dermatitis-with-targeted-therapies 2023-04-11 0.50 https://www.hcplive.com/peer-exchange/updates-in-the-management-of-alagille-syndrome 2022-06-03 0.50 https://www.hcplive.com/peer-exchange/evolving-strategies-for-cholesterol-management-and-atherosclerotic-cardiovascular-disease-risk 2022-10-14 0.50 https://www.hcplive.com/peer-exchange/optimizing-treatment-strategies-to-manage-inflammatory-bowel-disease 2023-01-16 0.50 https://www.hcplive.com/peer-exchange/peer-exchange-evolving-perspectives-and-treatment-strategies-in-chronic-spontaneous-urticaria 2024-10-21 0.50 https://www.hcplive.com/peer-exchange/advancing-sjogren-s-disease-care-emerging-therapies-and-clinical-insights 2025-11-20 0.50 https://www.hcplive.com/peer-exchange/novel-approaches-to-diagnosing-and-treating-generalized-pustular-psoriasis 2025-02-06 0.50 https://www.hcplive.com/peer-exchange/optimizing-cardiovascular-health-advancements-in-ldl-cholesterol-management-through-intensive 2024-05-01 0.50 https://www.hcplive.com/peer-exchange/navigating-the-evolving-landscape-of-adalimumab-biosimilars-for-inflammatory-disease 2024-05-13 0.50 https://www.hcplive.com/peer-exchange/identifying-rare-dermatologic-disorders-in-the-critical-care-setting 2023-04-06 0.50 https://www.hcplive.com/peer-exchange/exploring-the-role-of-oral-jak-inhibitors-in-atopic-dermatitis 2025-05-23 0.50 https://www.hcplive.com/peer-exchange/chronic-spontaneous-urticaria-and-bruton-tyrosine-kinase-a-multispecialty-expert-discussion 2025-05-27 0.50 https://www.hcplive.com/peer-exchange/the-future-of-type-1-diabetes-management 2022-12-21 0.50 https://www.hcplive.com/peer-exchange/advances-in-oral-systemic-treatments-for-management-of-atopic-dermatitis 2024-09-04 0.50 https://www.hcplive.com/peer-exchange/new-guidance-new-data-and-new-targets-for-the-management-of-hyperlipidemia 2023-09-05 0.50 https://www.hcplive.com/peer-exchange/multidisciplinary-approaches-to-the-management-of-atopic-dermatitis 2025-05-27 0.50 https://www.hcplive.com/peer-exchange/strategies-and-options-for-the-management-of-hypoglycemic-emergencies 2021-05-20 0.50 https://www.hcplive.com/peer-exchange/management-strategies-and-new-directions-in-the-treatment-of-vitiligo 2022-06-29 0.50 https://www.hcplive.com/peer-exchange/breaking-barriers-in-attr-cm-focusing-in-on-emerging-therapies 2025-04-07 0.50 https://www.hcplive.com/peer-exchange/allergies-asthma-exacerbations-and-uncontrolled-asthma-management 2024-05-08 0.50 https://www.hcplive.com/peer-exchange/beyond-the-event-optimizing-pcsk9-targeting-therapies-in-secondary-ascvd-prevention 2025-11-17 0.50 https://www.hcplive.com/peer-exchange/advances-in-the-clinical-management-of-diabetic-macular-edema-and-age-related-macular-degenerati 2022-06-24 0.50 https://www.hcplive.com/peer-exchange/optimal-management-of-biologics-in-crohn-s-disease 2022-11-22 0.50 https://www.hcplive.com/peer-exchange/navigating-hypoparathyroidism-understanding-the-multisystem-burden-and-optimizing-patient-care 2026-06-11 0.50 https://www.hcplive.com/peer-exchange/transforming-retinal-disease-management-with-novel-therapies 2024-05-13 0.50 https://www.hcplive.com/peer-exchange/expanding-horizons-on-who-can-benefit-from-non-statin-ldl-cholesterol-lowering-therapy-for 2023-12-07 0.50 https://www.hcplive.com/peer-exchange/from-ldl-c-to-lp-a-a-multispecialty-approach-to-reducing-the-rising-tide-of-cardiovascular-disease 2025-05-23 0.50 https://www.hcplive.com/peer-exchange/evolving-management-of-eosinophilic-esophagitis-from-diagnosis-to-early-intervention 2025-06-30 0.50 https://www.hcplive.com/peer-exchange/evolving-perspectives-and-treatment-strategies-in-chronic-spontaneous-urticaria 2024-10-30 0.50 https://www.hcplive.com/peer-exchange/simplifying-hiv-treatment-in-the-presence-of-drug-resistance-preventing-from-the-start 2024-05-17 0.50 https://www.hcplive.com/peer-exchange/management-of-wet-age-related-macular-degeneration 2021-12-21 0.50 https://www.hcplive.com/peer-exchange/advancing-hfpef-treatment-with-novel-mras 2025-10-07 0.50 https://www.hcplive.com/peer-exchange/diagnosis-and-treatment-of-immune-mediated-kidney-diseases 2023-04-12 0.50 https://www.hcplive.com/peer-exchange/recent-advances-in-treatment-of-alopecia-areata 2024-10-14 0.50 https://www.hcplive.com/peer-exchange/expert-guidance-on-novel-treatment-approaches-in-obstructive-hypertrophic-cardiomyopathy 2023-08-17 0.50 https://www.hcplive.com/peer-exchange/treatment-advances-and-evolving-standard-of-care-in-atopic-dermatitis 2024-12-23 0.50 https://www.hcplive.com/peer-exchange/rethinking-treatment-goals-in-psoriasis-leveraging-il-17-inhibitors-to-move-beyond-skin 2025-11-13 0.50 https://www.hcplive.com/peer-exchange/improving-access-to-alternative-therapies-for-treatment-resistant-depression 2022-03-30 0.50 https://www.hcplive.com/peer-exchange/the-opioid-crisis-a-multidisciplinary-perspective-on-effective-management 2023-01-16 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-advances-in-the-management-of-c-difficile 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-in-the-management-of-atopic-dermatitis-in-skin-of-color 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/evolving-management-strategies-for-treatment-resistant-depression 2021-05-20 0.50 https://www.hcplive.com/peer-exchange/paradigm-shifts-in-lipid-lowering 2024-07-08 0.50 https://www.hcplive.com/peer-exchange/practical-approaches-to-the-management-of-plaque-psoriasis-2020 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/paradigm-shift-in-lipid-management-px-2020 2024-07-08 0.50 https://www.hcplive.com/peer-exchange/biologic-treatment-considerations-for-asthma-during-the-covid-19-pandemic-and-the-upcoming-flu-season 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/case-based-evidence-for-cardiovascular-risk-reduction 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-the-optimal-management-of-sickle-cell-disease 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/adv-peripheral-arterial 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/advances-in-heart-failure-management 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/advances-management-inflammatorybowel-disease 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/advances-plaque-psoriasis 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/advances-sickle-cell-disease 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/alzheimer-disease-advice 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/best-practices-clostridium-difficile 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/best-practices-treatment-options-heart-failure-management 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/biomarkers-paradigm-asthma 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/biomarkers-severe-asthma 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/breakthrough-cancer-pain 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/cardioprotective-diabetes 2023-01-12 0.50 https://www.hcplive.com/peer-exchange/clostridium-difficile-infections 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/copd-individualized-approach 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/diabetes-individualizing-treatment 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/early-diagnosis-dementia 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/evaluation-management-rheumatic-disease-case-base-review 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-management-of-acute-myeloid-leukemia 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/heart-failure-2016 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/heart-failure-risk-reduction 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/hepatic-encephalopathy 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/hiv-optimizing-outcomes 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/hiv-treatment-landscape 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/hsct-infection-control 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/incarcerated-schizophrenia 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/irritable-bowel-syndrome 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/latest-developments-in-copd-therapy 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/manage-beta-thalassemia 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/manage-cad-pad 2024-07-08 0.50 https://www.hcplive.com/peer-exchange/manage-cardiac-amyloidosis 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/managing-chronic-pain 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/managing-postoperative-ileus 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/managing-type-2-diabetes-2016 2024-07-08 0.50 https://www.hcplive.com/peer-exchange/modifying-multiple-sclerosis 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/multiple-sclerosis-2015 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/noac-anticoagulation 2023-01-12 0.50 https://www.hcplive.com/peer-exchange/novel-anticoagulation-options 2023-01-12 0.50 https://www.hcplive.com/peer-exchange/opioid-constipation 2023-01-12 0.50 https://www.hcplive.com/peer-exchange/optimized-dyslipidemia-management 2024-07-08 0.50 https://www.hcplive.com/peer-exchange/optimizing-management-schizophrenia-lai-px 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/optimizing-outcomes-in-hiv-treatment 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/optimizing-treatment-of-pediatric-atopic-dermatitis 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/peerchronicpain 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/plaque-psoriasis-np-pa 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/rare-disorders 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/reducing-cardiometabolic-risk 2024-07-08 0.50 https://www.hcplive.com/peer-exchange/relapsing-remitting-multiple-sclerosis-2016 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/risk-cardiovascular 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/schizophrenia-treatment-prevention 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/severe-asthma-treatment 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/sickle-cell-disease-overview 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/substance_abuse_2016 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/therapeutic-strategies-copd-management 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/thromboprophylaxis 2023-01-12 0.50 https://www.hcplive.com/peer-exchange/transplant-infection-control 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/treatment-epilepsy 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/treatment-hemophilia 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/treatment-landscape-management-adhd 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/expert-perspectives-on-collaborative-management-of-atopic-dermatitis 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/applying-real-world-evidence-in-the-management-of-cad-pad 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/institutional-best-practices-for-treating-schizophrenia 2021-05-14 0.50 https://www.hcplive.com/peer-exchange/emerging-therapies-in-the-management-of-sickle-cell-disease 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/paradigm-shifts-in-the-management-of-plaque-psoriasis-advanced-practice-provider-perspectives 2021-12-08 0.50 https://www.hcplive.com/peers-and-perspective/expert-physician-assistant-and-nurse-practitioner-insights-on-the-management-of-plaque-psoriasis 2022-12-12 0.50 https://www.hcplive.com/peers-and-perspective/advances-in-colorectal-cancer-screening-strategies-in-clinical-practice 2026-03-09 0.50 https://www.hcplive.com/peers-and-perspective/telltale-signs-of-hepatic-encephalopathy-improving-diagnosis-in-in-patient-setting 2023-04-19 0.50 https://www.hcplive.com/peers-and-perspective/exploring-novel-tyk2-targeted-therapies-for-plaque-psoriasis 2023-03-31 0.50 https://www.hcplive.com/peers-and-perspective/advanced-practice-providers-perspectives-on-sleep-disorders-impact-of-insomnia-on-patient-health 2022-11-07 0.50 https://www.hcplive.com/peers-and-perspective/front-line-assessment-diagnosis-and-referral-for-alzheimer-disease 2025-06-17 0.50 https://www.hcplive.com/peers-and-perspective/extending-treatment-intervals-with-durable-therapies-for-namd-and-dme 2023-11-08 0.50 https://www.hcplive.com/peers-and-perspective/advancements-in-the-management-of-macular-edema-following-retinal-vein-occlusion 2021-12-14 0.50 https://www.hcplive.com/peers-and-perspective/taking-the-path-to-clearer-skin-targeted-treatment-through-il-23-inhibition-for-plaque-psoriasis 2023-11-07 0.50 https://www.hcplive.com/peers-and-perspective/integrating-novel-treatments-to-advance-schizophrenia-management 2025-07-11 0.50 https://www.hcplive.com/peers-and-perspective/optimizing-psoriasis-management-with-tyk2-inhibitors 2026-04-09 0.50 https://www.hcplive.com/peers-and-perspective/making-the-switch-in-atopic-dermatitis-optimizing-treatment-targets-with-jak-inhibitors 2025-07-10 0.50 https://www.hcplive.com/peers-and-perspective/tyk2-inhibition-evolving-options-in-psoriasis-care 2025-11-17 0.50 https://www.hcplive.com/peers-and-perspective/navigating-expanding-treatment-options-for-plaque-psoriasis-a-conversation-with-advanced 2023-09-26 0.50 https://www.hcplive.com/peers-and-perspective/treating-type-2-diabetes-today-and-tomorrow 2023-01-12 0.50 https://www.hcplive.com/peers-and-perspective/optimizing-care-in-atopic-dermatitis-advanced-practice-provider-insights-on-biologic-and 2023-12-11 0.50 https://www.hcplive.com/peers-and-perspective/exploring-biosimilars-for-the-treatment-of-retinal-vascular-diseases 2023-10-30 0.50 https://www.hcplive.com/peers-and-perspective/emerging-rnai-based-therapies-for-fcs-dyslipidemia 2024-09-19 0.50 https://www.hcplive.com/peers-and-perspective/navigating-csu-in-dermatology-advancing-care-with-evolving-strategies 2026-06-19 0.50 https://www.hcplive.com/peers-and-perspective/advances-in-the-management-of-major-depressive-disorder 2023-12-12 0.50 https://www.hcplive.com/peers-and-perspective/achieving-targeted-treatment-outcomes-in-ibd 2024-06-10 0.50 https://www.hcplive.com/peers-and-perspective/advanced-practice-provider-perspectives-on-the-long-term-safety-of-oral-plaque-psoriasis 2024-03-22 0.50 https://www.hcplive.com/peers-and-perspective/expert-perspectives-on-the-management-of-plaque-psoriasis 2022-09-12 0.50 https://www.hcplive.com/peers-and-perspective/treating-peripheral-arterial-disease-after-revascularization 2025-06-23 0.50 https://www.hcplive.com/peers-and-perspective/expanding-psoriasis-frontiers-emerging-treatment-pathways-and-advances-in-care 2025-10-02 0.50 https://www.hcplive.com/peers-and-perspective/expert-nurse-practitioner-physician-assistant-exchange-on-changing-treatment-approaches-in-the-m 2021-08-02 0.50 https://www.hcplive.com/peers-and-perspective/expert-perspectives-on-jak-inhibitors-in-dermatology-care 2022-09-23 0.50 https://www.hcplive.com/peers-and-perspective/best-practices-for-screening-and-diagnosis-of-type-1-diabetes-in-pediatric-patients 2022-12-22 0.50 https://www.hcplive.com/peers-and-perspective/importance-of-early-recognition-and-treatment-of-hepatic-encephalopathy 2023-04-19 0.50 https://www.hcplive.com/peers-and-perspective/optimizing-therapeutic-strategies-in-inflammatory-bowel-disease 2025-10-15 0.50 https://www.hcplive.com/peers-and-perspective/evolving-the-standard-of-care-in-retinal-vascular-diseases-with-next-generation-anti-vegf 2025-11-20 0.50 https://www.hcplive.com/peers-and-perspective/advances-in-insulin-delivery-systems 2022-11-22 0.50 https://www.hcplive.com/peers-and-perspective/oral-therapies-in-psoriasis-management-a-debate-on-deucravacitinib-vs-apremilast 2025-10-30 0.50 https://www.hcplive.com/peers-and-perspective/preparing-for-a-new-era-in-igan-treatment-staying-up-to-date-on-the-latest-developments-in 2023-11-21 0.50 https://www.hcplive.com/peers-and-perspective/treating-type-2-diabetes-looking-ahead 2023-01-12 0.50 https://www.hcplive.com/peers-and-perspective/expert-perspectives-on-the-updated-acc-decision-pathway-for-optimization-of-heart-failure-treatment 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/optimal-management-of-lipid-disorders-expert-nurse-practitioner-perspectives 2024-07-08 0.50 https://www.hcplive.com/peers-and-perspective/advances-in-the-management-of-wet-amd 2021-05-17 0.50 https://www.hcplive.com/peers-and-perspective/advances-in-the-management-of-hypercholesterolemia 2024-07-08 0.50 https://www.hcplive.com/peers-and-perspective/advances-in-the-management-of-complex-adhd-in-pediatric-patients 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/multidisciplinary-perspectives-on-the-management-of-plaque-psoriasis 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/antithrombosis-covid-19-prophylaxis-and-management 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/einstein-brain 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/health-it 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/heparin-shortage 2023-01-12 0.50 https://www.hcplive.com/peers-and-perspective/medical-malpractice 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/nutrition-elderly 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/reducing-cardiovascular-risk-during-coronavirus-19 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/schizophrenia-treatment 2021-05-14 0.50 https://www.hcplive.com/peers-and-perspective/optimal-management-of-diabetes-expert-nurse-practitioner-perspectives 2023-01-12 0.50 https://www.hcplive.com/peers-and-perspective/evaluating-the-diabetes-cardiology-interface 2023-01-12 0.50 https://www.hcplive.com/peers-and-perspective/expert-perspectives-on-the-optimal-management-of-inflammatory-bowel-disease 2023-01-16 0.50 https://www.hcplive.com/peers-and-perspective/best-practices-in-the-management-of-ibd-during-covid-19 2021-05-14 0.50 https://www.hcplive.com/cure-connections/generalized-pustular-psoriasis-recognizing-signs-symptoms-and-its-impact-on-patients 2024-03-25 0.50 https://www.hcplive.com/cure-connections/atopic-dermatitis-the-patient-journey 2023-04-07 0.50 https://www.hcplive.com/cure-connections/enhancing-pnh-care-collaborative-decision-making-and-improving-patient-experience 2024-12-19 0.50 https://www.hcplive.com/cure-connections/the-sickle-cell-disease-patient-journey 2023-04-11 0.50 https://www.hcplive.com/cure-connections/the-alopecia-areata-patient-journey 2025-05-23 0.50 https://www.hcplive.com/cure-connections/choosing-biologics-with-confidence-in-ibd-a-patient-s-journey-from-diagnosis-to-remission 2026-06-01 0.50 https://www.hcplive.com/cure-connections/barriers-to-addressing-sleep-health-in-clinical-practice 2025-05-23 0.50 https://www.hcplive.com/cure-connections/the-vitiligo-patient-journey 2023-05-30 0.50 https://www.hcplive.com/cure-connections/understanding-and-managing-familial-chylomicronemia-syndrome 2025-05-23 0.50 https://www.hcplive.com/insights/modern-management-of-indolent-systemic-mastocytosis-clinical-practice-and-emerging-evidence 2026-03-16 0.50 https://www.hcplive.com/insights/optimal-management-of-opioid-induced-constipation 2023-01-12 0.50 https://www.hcplive.com/insights/advancing-treatment-in-indolent-systemic-mastocytosis-updates-at-eaaci-2025 2025-07-14 0.50 https://www.hcplive.com/insights/what-is-on-the-horizon-for-rheumatology-in-2023 2022-12-02 0.50 https://www.hcplive.com/insights/taking-the-path-to-clearer-skin-targeted-treatment-through-il-23-inhibition-for-plaque-psoriasis 2023-11-15 0.50 https://www.hcplive.com/insights/breaking-barriers-safely-targeting-obstructive-hypertrophic-cardiomyopathy 2024-10-23 0.50 https://www.hcplive.com/insights/the-significance-of-achieving-optimal-treatment-targets-in-atopic-dermatitis 2024-07-12 0.50 https://www.hcplive.com/insights/the-evolving-treatment-paradigm-for-chronic-spontaneous-urticaria-management 2025-06-26 0.50 https://www.hcplive.com/insights/expert-perspectives-on-advances-in-precision-medicine-in-treating-rheumatoid-arthritis 2023-02-13 0.50 https://www.hcplive.com/insights/emerging-treatment-options-for-the-management-of-moderate-to-severe-psoriasis 2022-02-10 0.50 https://www.hcplive.com/insights/chronic-hand-eczema-clinical-insights-patient-experience-and-emerging-therapeutics 2025-04-24 0.50 https://www.hcplive.com/insights/new-evidence-for-tailoring-heart-failure-therapy-an-expert-approach-to-patient-centered-care 2023-06-27 0.50 https://www.hcplive.com/insights/impact-of-anemia-hemolysis-in-sickle-cell-disease 2021-08-04 0.50 https://www.hcplive.com/insights/management-of-idiopathic-pulmonary-fibrosis 2021-11-10 0.50 https://www.hcplive.com/insights/iron-deficiency-anemia-diagnosis-management-special-populations-and-the-evolving-evidence-base 2026-03-25 0.50 https://www.hcplive.com/insights/educated-patient-management-of-fibromyalgia 2024-08-14 0.50 https://www.hcplive.com/insights/latest-advances-in-the-management-of-atopic-dermatitis 2022-12-22 0.50 https://www.hcplive.com/insights/utilization-of-biosimilars-in-retinal-diseases 2022-07-28 0.50 https://www.hcplive.com/insights/alopecia-areata-patient-identification-access-and-treatment-decision 2026-06-05 0.50 https://www.hcplive.com/insights/examining-key-aspects-of-colorectal-cancer-screening-a-path-to-preventing-late-stage-cancer 2024-11-11 0.50 https://www.hcplive.com/insights/breaking-down-the-dora-class-in-the-treatment-of-insomnia 2025-05-13 0.50 https://www.hcplive.com/insights/evaluating-latest-evidence-and-treatment-targets-in-moderate-to-severe-atopic-dermatitis 2025-05-23 0.50 https://www.hcplive.com/insights/long-term-use-and-safety-of-jak-inhibitors-and-evaluating-efficacy-outcomes-in-atopic-dermatitis 2023-06-06 0.50 https://www.hcplive.com/insights/considerations-for-the-management-of-hypoglycemia-and-diabetes-in-schools 2022-08-30 0.50 https://www.hcplive.com/insights/the-latest-breakthroughs-in-emerging-oral-systemic-treatments-for-plaque-psoriasis 2024-03-11 0.50 https://www.hcplive.com/insights/emerging-treatment-approaches-for-iga-nephropathy-taking-a-deep-dive-into-targeted-immune 2023-09-25 0.50 https://www.hcplive.com/insights/cortisol-and-type-2-diabetes-what-patients-need-to-know 2026-06-09 0.50 https://www.hcplive.com/insights/optimal-management-of-adhd-in-pediatric-population 2021-11-09 0.50 https://www.hcplive.com/insights/reducing-treatment-burden-in-ibd-with-at-home-therapy-options 2024-08-07 0.50 https://www.hcplive.com/insights/emerging-treatment-options-in-patients-with-difficult-to-treat-hypertension 2025-05-12 0.50 https://www.hcplive.com/insights/advancing-allergy-practice-in-csu-from-pathophysiology-to-patient-centered-care 2025-11-20 0.50 https://www.hcplive.com/insights/expert-insight-into-the-efficacy-and-economic-burden-of-opioid-induced-constipation-treatments 2022-06-03 0.50 https://www.hcplive.com/insights/optimizing-treatment-pathways-in-chronic-spontaneous-urticaria 2025-11-06 0.50 https://www.hcplive.com/insights/optimizing-screening-and-diagnosis-of-type-1-diabetes 2022-10-25 0.50 https://www.hcplive.com/insights/optimizing-surgical-approaches-for-sustained-delivery-of-anti-vegf-in-neovascular-amd 2024-07-19 0.50 https://www.hcplive.com/insights/taking-a-deep-dive-into-precision-medicine-for-obstructive-hypertrophic-cardiomyopathy 2024-02-14 0.50 https://www.hcplive.com/insights/an-expert-approach-to-individualizing-care-for-patients-with-fibromyalgia 2023-11-29 0.50 https://www.hcplive.com/insights/redefining-psoriatic-care-new-data-new-standards 2025-10-20 0.50 https://www.hcplive.com/insights/case-based-insights-expert-perspectives-on-the-treatment-of-adult-onset-sma 2021-07-01 0.50 https://www.hcplive.com/insights/treatment-of-rare-systemic-autoimmune-rheumatic-diseases-sards-systemic-lupus-erythematous-sle-a 2021-05-19 0.50 https://www.hcplive.com/insights/onboarding-patients-on-jak-inhibitors-for-atopic-dermatitis 2024-07-12 0.50 https://www.hcplive.com/insights/understanding-and-treating-vitiligo 2021-12-20 0.50 https://www.hcplive.com/insights/cardiovascular-risk-management-in-patients-with-diabetes 2021-05-20 0.50 https://www.hcplive.com/insights/addressing-treatment-dilemmas-in-neovascular-amd-and-dme 2024-03-13 0.50 https://www.hcplive.com/insights/insomnia-and-sleep-disorders-in-primary-care-settings 2022-10-28 0.50 https://www.hcplive.com/insights/expert-perspectives-on-updates-in-the-management-of-ulcerative-colitis 2022-07-29 0.50 https://www.hcplive.com/insights/latest-advances-in-the-management-of-vitiligo 2022-12-22 0.50 https://www.hcplive.com/insights/advances-in-the-management-of-age-related-macular-degeneration 2021-05-14 0.50 https://www.hcplive.com/insights/optimal-management-of-plaque-psoriasis-expert-nurse-practitioner-perspectives-2020 2021-05-14 0.50 https://www.hcplive.com/insights/institution-focused-management-of-schizophrenia 2021-05-14 0.50 https://www.hcplive.com/insights/evaluation-and-management-of-rheumatic-diseases-a-case-based-review-dr-wright 2021-05-14 0.50 https://www.hcplive.com/insights/hope-voxelotor-for-treating-sickle-cell-disease 2021-05-14 0.50 https://www.hcplive.com/insights/evaluation-of-spinal-muscular-atrophy-in-the-era-of-telehealth 2021-05-14 0.50 https://www.hcplive.com/insights/treating-advanced-rai-refractory-dtc-a-two-way-street-medical-oncology-and-endocrinology 2021-05-14 0.50 https://www.hcplive.com/insights/evaluation-and-management-of-rheumatic-diseases-a-case-based-review 2021-05-14 0.50 https://www.hcplive.com/insights/expert-perspectives-on-the-clinical-impact-of-non-medical-therapeutic-switching 2021-05-14 0.50 https://www.hcplive.com/insights/collaborative-management-of-atopic-dermatitis 2021-05-14 0.50 https://www.hcplive.com/insights/advances-cad-t2dm-treatment 2021-05-14 0.50 https://www.hcplive.com/insights/advances-depression 2021-05-14 0.50 https://www.hcplive.com/insights/cardiometabolic-syndrome 2021-05-14 0.50 https://www.hcplive.com/insights/crohns-disease 2021-05-14 0.50 https://www.hcplive.com/insights/early-diagnosis-mm 2021-05-14 0.50 https://www.hcplive.com/insights/geriatric-patient-outcomes 2021-05-14 0.50 https://www.hcplive.com/insights/glp1-diabetes 2023-01-12 0.50 https://www.hcplive.com/insights/hidradenitis-suppurativa 2021-05-14 0.50 https://www.hcplive.com/insights/insomnia-elderly 2021-05-14 0.50 https://www.hcplive.com/insights/malnutrition_and_sarcopenia 2021-05-14 0.50 https://www.hcplive.com/insights/manage-hypercholesterolemia 2024-07-08 0.50 https://www.hcplive.com/insights/manage-plaque-psoriasis 2021-05-14 0.50 https://www.hcplive.com/insights/mdr-treatment 2021-05-14 0.50 https://www.hcplive.com/insights/multiple-sclerosis 2021-05-14 0.50 https://www.hcplive.com/insights/optimizing-insulin-diabetes 2023-01-12 0.50 https://www.hcplive.com/insights/racial-disparities-cardiovascular-disease 2023-01-12 0.50 https://www.hcplive.com/insights/spa-management 2026-01-15 0.50 https://www.hcplive.com/insights/optimal-management-of-adhd 2021-05-14 0.50 https://www.hcplive.com/insights/a-review-of-treatment-options-for-the-management-of-sickle-cell-disease 2021-05-14 0.50 https://www.hcplive.com/podcasts/diabetes-dialogue 2026-07-15 0.50 https://www.hcplive.com/podcasts/kidney-compass 2026-07-15 0.50 https://www.hcplive.com/podcasts/moving-the-needle-podcast 2026-07-15 0.50 https://www.hcplive.com/podcasts/dont-miss-a-beat 2026-07-15 0.50 https://www.hcplive.com/podcasts/liver-lineup-updates-unfiltered-insights 2026-07-15 0.50 https://www.hcplive.com/podcasts/medical-ethics-unpacked 2026-07-15 0.50 https://www.hcplive.com/podcasts/the-medical-sisterhood 2026-07-15 0.50 https://www.hcplive.com/podcasts/socs-podcast 2026-07-15 0.50 https://www.hcplive.com/podcasts/abcs-in-dermatology 2026-07-15 0.50 https://www.hcplive.com/shows/medcasts 2022-12-14 0.50 https://www.hcplive.com/special-report/navigating-updates-in-colorectal-cancer-screening 2024-08-15 0.50 https://www.hcplive.com/special-report/hfsa-aahfn-joint-statement-on-tech-integration-in-heart-failure 2026-03-05 0.50 https://www.hcplive.com/special-report/breaking-down-the-new-dietary-guidelines-2025-2030-evidence-gaps-and-real-world-practice 2026-02-04 0.50 https://www.hcplive.com/special-report/rx-review-integrating-new-topicals-into-scalp-psoriasis-treatment-regimens 2025-07-11 0.50 https://www.hcplive.com/special-report/optimizing-the-use-potential-of-lipoprotein-apheresis 2024-10-17 0.50 https://www.hcplive.com/special-report/navigating-hypercortisolism-management-in-2026 2026-02-06 0.50 https://www.hcplive.com/special-report/the-changing-landscape-of-glomerular-disease-research-and-treatment 2026-03-06 0.50 https://www.hcplive.com/special-report/optimizing-diagnosis-and-management-of-fcs-in-2026 2026-06-15 0.50 https://www.hcplive.com/special-report/bridging-gut-and-skin-care-a-call-for-collaboration-in-inflammatory-disease-management 2025-06-24 0.50 https://www.hcplive.com/special-report/new-pediatric-atopic-dermatitis-guidelines-what-clinicians-need-to-know 2026-06-04 0.50 https://www.hcplive.com/special-report/rx-review-updates-and-unmet-needs-in-hfmref-hfpef-the-role-of-finerenone 2025-08-01 0.50 https://www.hcplive.com/special-report/how-approval-of-resmetirom-impacts-management-screening-for-nash 2024-08-15 0.50 https://www.hcplive.com/special-report/rx-review-new-era-disease-modifying-therapy-bronchiectasis 2025-08-26 0.50 https://www.hcplive.com/special-report/rx-review-the-evolving-landscape-of-rsv-prevention-in-pediatrics-and-beyond 2025-06-16 0.50 https://www.hcplive.com/special-report/updates-in-atopic-dermatitis-and-psoriasis-in-pediatric-patients 2026-01-02 0.50 https://www.hcplive.com/special-report/four-year-efficacy-and-safety-data-of-ustekinumab-use-in-ulcerative-colitis 2022-11-16 0.50 https://www.hcplive.com/special-report/updates-and-advances-in-the-management-of-hs 2023-07-14 0.50 https://www.hcplive.com/special-report/advances-management-geographic-atrophy 2024-04-30 0.50 https://www.hcplive.com/special-report/understanding-recent-updates-in-iga-nephropathy-pipeline 2024-10-30 0.50 https://www.hcplive.com/special-report/understanding-and-applying-updates-in-thyroid-eye-disease 2025-12-16 0.50 https://www.hcplive.com/special-report/evaluating-therapeutic-options-in-fcs 2026-01-08 0.50 https://www.hcplive.com/special-report/projecting-a-role-for-psychedelic-therapies-in-psychiatry-with-gus-alva-md 2024-08-05 0.50 https://www.hcplive.com/special-report/unmet-needs-and-challenges-in-allergy-management 2026-02-10 0.50 https://www.hcplive.com/special-report/updates-and-unmet-needs-in-c3g-the-role-of-pegcetacoplan 2025-08-04 0.50 https://www.hcplive.com/special-report/2026-media-day-with-uchicago-medicine 2026-02-27 0.50 https://www.hcplive.com/special-report/risankizumab-in-psoriatic-disease-new-evidence-on-prevention-long-term-efficacy-and-safety 2026-06-30 0.50 https://www.hcplive.com/special-report/navigating-safety-and-rems-programs-in-ohcm-care 2026-03-16 0.50 https://www.hcplive.com/special-report/evolving-landscape-of-hypoparathyroidism-exploring-the-role-of-palopegteriparatide 2026-07-13 0.50 https://www.hcplive.com/special-report/emerging-role-of-seladelpar-in-pbc-care 2024-12-04 0.50 https://www.hcplive.com/special-report/pde4-inhibitors-in-treatment-of-plaque-psoriasis 2022-11-18 0.50 https://www.hcplive.com/special-report/embracing-new-therapies-in-schizophrenia-management 2024-10-07 0.50 https://www.hcplive.com/special-report/behind-the-guidelines-understanding-2026-acc-aha-dyslipidemia-guidelines 2026-03-23 0.50 https://www.hcplive.com/special-report/updates-in-cutaneous-lupus-erythematosus-from-aad-2026 2026-03-31 0.50 https://www.hcplive.com/special-report/updates-in-the-treatment-landscape-of-chronic-spontaneous-urticaria 2025-11-24 0.50 https://www.hcplive.com/special-report/rethinking-chronic-kidney-disease-and-cardiovascular-care 2024-10-30 0.50 https://www.hcplive.com/special-report/hfsa-aspc-joint-statement-on-shifting-the-focus-for-heart-failure 2025-09-09 0.50 https://www.hcplive.com/special-report/csu-management-updates-2026-guidelines-and-latest-data 2026-03-18 0.50 https://www.hcplive.com/special-report/understanding-lebrikizumab-for-atopic-dermatitis-in-skin-of-color 2025-06-16 0.50 https://www.hcplive.com/special-report/rx-review-monoclonal-antibodies-for-copd-management 2025-07-30 0.50 https://www.hcplive.com/special-report/understanding-the-potential-of-mdma-assisted-therapy-in-ptsd 2024-08-05 0.50 https://www.hcplive.com/special-report/updates-and-unmet-needs-in-pbc 2024-08-15 0.50 https://www.hcplive.com/special-report/recapping-ash-hematology-updates-from-2024 2024-12-17 0.50 https://www.hcplive.com/special-report/advances-in-pediatric-fc-ibs-c-treatment-and-care 2026-06-05 0.50 https://www.hcplive.com/special-report/rx-review-leveraging-sirna-in-fcs-management 2025-11-26 0.50 https://www.hcplive.com/special-report/psoriasis-treatment-selection-route-of-administration-and-comparative-effectiveness 2026-05-14 0.50 https://www.hcplive.com/special-report/rx-review-updates-in-pediatric-food-allergy-and-anaphylaxis-for-2025 2025-03-11 0.50 https://www.hcplive.com/special-report/advancements-and-insights-from-the-obesity-medicine-association-conference-2026 2026-06-22 0.50 https://www.hcplive.com/special-report/weight-loss-pharmacotherapy-beyond-incretins-patient-selection-safety-and-real-world-decision 2026-02-02 0.50 https://www.hcplive.com/special-report/switching-therapeutic-classes-in-atopic-dermatitis 2025-11-26 0.50 https://www.hcplive.com/special-report/emerging-therapies-for-the-management-of-ulcerative-colitis 2021-06-02 0.50 https://www.hcplive.com/special-report/rx-review-understanding-attr-cm--new-era-of-management 2025-03-28 0.50 https://www.hcplive.com/special-report/embracing-the-ppar-agonist-era-of-pbc-management 2024-08-15 0.50 https://www.hcplive.com/special-report/iron-deficiency-anemia-underdiagnosis-early-treatment-intravenous-iron-management-and-clinical 2026-05-12 0.50 https://www.hcplive.com/special-report/updates-unmet-need-in-hepatitis-b-management-2024 2024-08-15 0.50 https://www.hcplive.com/special-report/embracing-il-17-a-f-inhibition-for-hidradenitis-suppurativa-dermatologic-conditions 2024-12-05 0.50 https://www.hcplive.com/special-report/guideline-updates-for-chronic-spontaneous-urticaria-management 2026-03-11 0.50 https://www.hcplive.com/special-report/addressing-pruritus-in-primary-biliary-cholangitis 2024-12-05 0.50 https://www.hcplive.com/special-report/beyond-type-2-classifying-diabetes-and-screening-for-hypercortisolism-in-the-2026-aace-algorithm 2026-06-12 0.50 https://www.hcplive.com/special-report/practical-approach-to-treating-growth-hormone-deficiency-how-to-leverage-registries-to-guide 2026-07-08 0.50 https://www.hcplive.com/special-report/celebrating-1-year-of-resmetirom-progress-in-mash-masld 2025-03-13 0.50 https://www.hcplive.com/special-report/usmstf-guidance-on-optimizing-bowel-preparation-for-colonoscopy 2025-03-19 0.50 https://www.hcplive.com/special-report/rx-review-how-approval-of-aficamten-impacts-ohcm-care 2026-01-21 0.50 https://www.hcplive.com/special-report/advancing-long-term-arthritis-care-at-acr-2020 2021-05-14 0.50 https://www.hcplive.com/special-report/early-initiation-lais-schizophrenia 2021-05-14 0.50